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ABSTRACT
Background: The effect of intensity and duration of physical ac-
tivity (PA) on weight loss has been well described. However, the
effect of the frequency of weekly PA on weight loss is still un-
known.
Objective: The purpose of this study was to evaluate the effect of
the frequency of weekly PA sessions while maintaining the same total
activity time on weight loss during a 24-wk weight loss program.
Design: Overweight and obese women [n = 75; body mass index
(BMI; in kg/m2): 27–37; age: 18–40 y] who had a normally sed-
entary lifestyle were randomly allocated to 1 of 2 intervention
groups: a high-frequency physical activity (HF) or a low-frequency
physical activity (LF) group. The HF group included 50 min/d PA,
6 d/wk (300 min/wk). The LF group included 100 min/d PA, 3 d/wk
(300 min/wk). Both groups were advised to follow the same dietary
weight loss program.
Results: Both groups showed a significant decrease in anthropomet-
ric measurements and significant improvements in cardiometabolic
disease risk characteristics over the 24 wk of the study. Compared
with the HF group, the LF group had a greater decrease in weight
(mean 6 SD; LF: 9.58 6 3.77 kg; HF: 7.78 6 2.68 kg; P = 0.028),
BMI (LF: 3.62 6 1.56; HF: 2.97 6 1.02; P = 0.029) and waist
circumference (LF: 9.366 4.02 cm; HF: 7.866 2.41 cm; P = 0.031).
However, there were no significant differences in carbohydrate me-
tabolism characteristics or lipid profile after the 24 wk of intervention.
Conclusion: Weekly PA undertaken over fewer sessions of longer
duration during the week could be more effective for weight loss than
when undertaken as more frequent shorter sessions in overweight
and obese women on a weight loss program. This may be helpful
for those who are neither willing nor able to schedule time for
PA almost every day to achieve weight loss. This trial was regis-
tered at www.irct.ir as IRCT201402157754N4. Am J Clin Nutr
doi: 10.3945/ajcn.116.136408.
Keywords: physical activity pattern, obesity, weight loss diet,
waist circumference, cardiometabolic disease risk
INTRODUCTION
Physical activity (PA)6 is recommended as a component
of weight management (1, 2), as well as in the treatment of
abdominal obesity (3). It is well known that weight loss inter-
ventions that include PA are more effective than dietary instruction
alone for promoting long-term weight loss (4, 5).
Previous guidelines recommended 150 min of moderate to
vigorous PA achieved by participating in $30 min of moderate
to vigorous PA on most or all days of the week (6). Present
guidelines (7–9) advise that adults undertake moderate to vig-
orous PA for $150 min/wk, in sessions of $10 min (7, 8).
However, The American College of Sports Medicine recommended
200–300 min/wk for long-term weight loss (10). Current prac-
tice guidelines include recommendations that PA be undertaken
for 30 min/d for most days of the week, increasing, when ap-
propriate, to 60 min/d (11, 12). In the more recent guidelines,
however, there is no recommendation about the frequency of PA
throughout the week (9, 13). Limited studies have assessed the
frequency of PA participation during the week and its relation
with health, not weight loss. A cohort study (14) compared the
effect of being a “weekend warrior” (1–2 d/wk) with being active
regularly with respect to the risk of mortality. There was some
indication that more frequent PA could deliver additional health
benefits (14). However, a recent observational study (15) found that
the frequency of moderate to vigorous PA during the week is not as
important as the total length of time spent being physically active.
Therefore, although the implications of total time and intensity
of PA have been studied, it is less clear whether frequency of
sessions matters. Activity pattern may have important implica-
tions for compliance with an activity program during weight
management. A lack of time is often mentioned as a barrier to PA.
Advocating any one pattern of activity over the week, without
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evidence of it being particularly beneficial, would unnecessarily
limit flexibility and the opportunity to undertake activity around
other fixed commitments, hence reducing compliance. It is im-
portant to establish, e.g., whether it is necessary to be physically
active every day of the week or whether similar weight loss
benefit can be obtained with less frequent PA, providing the total
amount of weekly PA is the same.
To our knowledge, no clinical trials have evaluated the effects on
weight loss of different frequencies of weekly PA sessions, with
a fixed duration of total activity, when combined with a restricted
energy diet. Thus, the primary objective of the present study was to
compare the effects onweight loss and anthropometric measures of
brisk walking for a fixed total duration per week, when undertaken
either over 6 d of the week, or over 3 d of the week, in healthy
overweight and obese women who were following a comprehen-
sive 24-wk weight loss program. The secondary objective was to
examine the effect of weekly PA frequency on biochemical in-
dicators of cardiometabolic disease risk.
METHODS
Participants
Healthy overweight and obese participants were selected
between March 2014 and April 2015 from patients attending the
NovinDiet Clinic in Tehran, Iran, to lose weight. Inclusion cri-
teria were the following: women aged 18–40 y, BMI (in kg/m2):
27–35, sedentary lifestyle [reported exercising ,3 d/wk for
,20 min/d for the previous 6 mo (16, 17)] and willing to intro-
duce dietary changes to lose weight. All participants were required
to be nonsmokers who were free of established cardiovascular
diseases, stroke, diabetes, liver or kidney disease, depression,
cancer, or autoimmune disease. Moreover, participants included
those who were able to prove that they could keep an adequate
4-d food record and record details of their total daily steps, and
who were considered fit to participate in the physical exercise
program by the study physician. Exclusion criteria were pregnancy
or lactation during the previous 6 mo or planning a pregnancy in
the next 6 mo; depression as defined by Beck’s Depression In-
ventory (18); weight loss $10% of body weight within the 6 mo
before enrollment in the study; participation in a research proj-
ect involving weight loss or PA in the previous 6 mo; taking
medication to lower lipids or cholesterol or medication that could
affect metabolism or change body weight, including birth control
medication; reported heart disorders, frequent chest pains, or faint-
ness or dizziness on the Physical Activity Readiness Question-
naire (19); or being considered unfit to participate by the study
physician as a result of any other medical condition.
The study (IRCT201402157754N4) was approved by the eth-
ical committee of the Digestive Research Institute, Tehran Uni-
versity ofMedical Science. All participants provided their informed,
signed consent before participating in this study.
Study design and interventions
The study was a 24-wk, 2-arm, single-blind randomized
clinical trial. Eligible participants were allocated randomly after
baseline measurements by the project director with the use of
a computer-generated random-numbers method. Allocation was
concealed from the participants and dietitians until randomization
was revealed to the study participants at the first intervention clinic
appointment. Seventy-five subjects were randomly assigned to 1 of
the 2 study groups: 1) diet plus high-frequency physical activity
(HF) (n = 38), or 2) diet plus low-frequency physical activity (LF)
(n = 37). To control the effects of menstrual cycle on measure-
ments, participants started the study at the same phase of their
menstrual cycle. Subjects in the HF group were requested to
perform 50 min/d brisk walking, 6 d/wk (300 min/wk). Subjects
in the LF group were instructed to perform 100 min/d brisk
walking, 3 d/wk (300 min/wk).
To become conditioned to the level of exercise a week
before the start of the study, participants were asked to increase
their daily step count and record their total daily step count. To
standardize the intensity of the PA sessions, participants were
asked to walk $100 steps/min during the brisk walking ses-
sions (20). Participants were asked to do brisk walking on
a flat surface outdoors in their neighborhood or in a park while
wearing loose-fitting and comfortable clothing appropriate for
weather conditions.
To encourage the participants to achieve the requested PA goal,
their treatment included encouragement to recruit a partner from
their group of friends and family members to participate in the
activity part of the study with them. Biweekly visits to the di-
etitian and exercise coach were required to promote adherence to
the hypoenergetic diet and recommended PA protocol. To promote
adherence to the PA intervention, participants were provided with
a 3-dimensional pedometer. Participants were instructed to wear
the pedometer for the whole day except when having a bath and
in bed. They were asked to keep a written record of their daily
step counts and time of their structured PA in their log book. Both
groups were advised on a hypoenergetic diet according to the
NovinDiet Protocol.
Dietary and activity intervention sessions
The NovinDiet Clinic is a privateweight loss clinic that uses an
integrated approach (dietary, behavioral, exercise, and medical
treatments). The NovinDiet Protocol is based on helping each
member develop his or her own problem solving approach. The
program was designed to enable weight loss of 7–10% of initial
body weight at a rate of 0.5–1 kg/wk over 24 wk. The individual
diet programs were based on the participant’s food diary re-
cords, which reflected their food preferences. Gradual modifi-
cations were made to bring their diet in line with the NovinDiet
protocol. Participants were encouraged to eat mainly foods with
low energy density to achieve satiety, some low-fat dairy prod-
ucts, fiber-rich foods, and controlled amounts of high energy–
dense foods. The main behavior change strategies applied included
assessing and discussing stages of change, goal setting, self-
monitoring with food diaries, and giving feedback on waist
measurement changes (21, 22).
At weekly sessions, the participants were encouraged to de-
scribe any problems complying with their weight loss program,
and these were discussed. Resources were provided as home
booklets that indicated the individual dietary and PA goals. During
the intervention period, participants completed a feedback form
regarding their adherence to diet and PA. At weekly clinic visits,
the dietitian reviewed their progress and also checked their PA
adherence and reported their step counts during the previous
week. Participants also had access to a Website, weekly Internet
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magazines, and one-on-one telephone or online support from
a consultant, if they felt that they had difficulty with compliance.
Measurements
Anthropometric measurements were taken at baseline and at
24 wk (except height, which was taken only at the screening
visit), by the dietitian.
Participants recorded their food intake at baseline, week 11, and
toward the end of the intervention (week 24). The records were
analyzed with the use of Nutritionist IV software (version 4.1;
Hearst). Estimated daily PA measurements of all participants were
taken at baseline and weeks 4, 8, 12, 16, 20, and 24 by using the 3D
pedometer. Blood samples were taken after an overnight (10–12 h)
fast, between 0700 and 0900, at baseline and 24 wk. Blood was
obtained from an antecubital vein via a venipuncture while the
participants were sitting, according to the standard protocol; this
was centrifuged within 30–45 min. Blood samples were also
taken 2 h after ingesting 75 g glucose according to the standard
method for 2-h postprandial (2hpp) glucose (23). Blood samples
were analyzed for biochemical, cellular, and hormonal variables.
Anthropometric measurements
Body weight was measured to the nearest 0.1 kg with the use
of a digital calibrated scale (Omron Health Care) while the
participants wore light clothing, with no shoes. Body height
was measured to the nearest 0.1 cm by using a wall mounted
stadiometer (SECA) without shoes, and with participants in a free-
standing position. Waist circumference (WC) (24) was measured
with a rigid measuring tape and recorded to the nearest 0.5 cm.
WC was measured at the smallest horizontal circumference
between the ribs and iliac crest (the natural waist), or, in case of
an indeterminable waist narrowing, halfway between the lower
rib and the iliac crest (25). BMI was calculated from measured
weight in kilograms divided by the square of height in meters.
Blood sample measurements
Fasting plasma glucose (FPG) and 2hpp glucose concentra-
tions were measured with the use of the enzymatic colorimetric
method, with intra- and interassay CVs ,2%. Insulin was
measured by using a radioimmunoassay with 125I-labeled human
insulin and a human insulin antiserum in an immunoradiometric
assay (Biosource) with a g-counter system (Gamma I; Genesys),
with intra- and interassay CVs ,2.3%. Insulin resistance was
evaluated by HOMA-IR, which was calculated by using the
following formula (26):
HOMA-IR ¼ ½fasting insulinðmU=LÞ3 FPGðmmol=LÞ=22:5
ð1Þ
Glycated hemoglobin was measured by a colorimetric method
after an initial separation by ion exchange chromatography (Bio-
system), with intra- and interassay CVs ,1.7%.
Biochemical analysis of serum total cholesterol (TC), tri-
glycerides, and HDL cholesterol was carried out on a Selectra E
auto analyzer (Vita Laboratory) while following standard
procedures for the Pars Azmoon diagnostic kits (Iran). Both
inter- and intra-assay CVs were ,1.8%, 2.9%, and 2.4% for
TC, HDL cholesterol, and triglycerides, respectively. LDL
cholesterol was calculated with the use of the Friedewald
formula (27):
LDL cholesterol ¼ TC2HDL cholesterolþ ðTGO2:2Þ ð2Þ
Statistical methods
Baseline values of cardiovascular disease risk factors (including
weight, WC, LDL cholesterol, HDL cholesterol, TC, FPG, tri-
glycerides, fasting insulin, HOMA-IR, glycated hemoglobin, 2hpp
glucose, food intake data, and step count data) were compared
between the HF and LF groups with the use of unpaired t tests.
At baseline, distribution was normal for all variables. All
participants who were assigned randomly and completed an
initial assessment were included in the final results by using an
intention-to-treat analysis. Multiple imputations with the use of
linear regression were used to impute missing values from 24 wk
and were based on the assumption that data weremissing at random.
We used ANCOVA to compare the mean of postintervention
outcomes between the 2 groups by adjustment of baseline values
as a covariate. Repeated-measures 2-factor ANOVA with interven-
tion groups (HF and LF) and time (weeks 0, 4, 8, 12, 16, 20, and
24) as a within-subject factor was used to assess the effects of the
interventions by comparing changes in the PA level measured by
using the step count data between the groups over time.
The primary outcome addressed in this study was the dif-
ference in body weight loss after the 24-wk weight loss program.
The power calculation was based on prior data [a = 0.05, power
(1 2 b) = 0.8], and was performed on the basis of expected
differences in weight loss between the intervention groups of 1.3
and an SD of61.9 kg to determine the targeted final sample size
(n = 66). When considering a dropout rate of 10%, the sample
size required was 73. Thus, 75 subjects were randomly assigned
to each of the 2 intervention groups.
Statistical significance was set at P # 0.05. All data are pre-
sented as means 6 SDs unless otherwise stated. All statistical
analyses were performed with the use of SPSS 22.0 for Windows.
RESULTS
Baseline characteristics
Of 97 individuals whowere interested in participating in the study,
2 were excluded from the study because of their results on Beck’s
Depression Inventory. Three potential participants were excluded
because they stopped keeping the dietary record or filled it in in-
sufficiently before random assignment. Five were excluded because
they decided that they were not interested in participating in the
study. Blood test results at baseline revealed that 12 patients were
ineligible because they had $1 of the exclusion criteria. The re-
maining 75 eligible participants gave written consent, and then 38
subjects were randomly allocated to the HF group and 37 were
allocated to the LF group. Fifty-nine completed the 24-wk in-
tervention (79% of the randomly assigned population) (Figure 1).
After the intervention started, a total of 16 participants dropped out
[5 because of illness (n = 2 in the LF group and n = 3 in the HF
group), 3 because they could not meet the time commitment (n = 1
in the LF group and n = 2 in the HF group), 1 because she expe-
rienced an unexpected pregnancy (LF group), 6 because they sub-
sequently lost interest (n = 4 in the LF group and n = 2 in the HF
group), and 1 because she moved away from the area (HF group)].
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At baseline, there were no statistically significant differences
in physical characteristics or biochemical measurements between
the intervention groups or between those who completed or did
not complete the study once recruited (Table 1).
Body weight, BMI, and WC
Therewas significantweight reduction in each group after 24wk
of study (P, 0.001) (Table 2). There was a significant difference
between groups after 24 wk of the intervention (P = 0.028) (Table 2).
BMI reduction in each group was in the expected direction,
with significant effects over 24 wk for both groups (P , 0.001).
Also, there was a significant difference between groups in BMI
reduction after 24 wk (P = 0.029) (Table 2).
In both groups, WC had decreased significantly after 24 wk of
intervention (P , 0.001). The mean WC decline was 9.36 6
4.02 cm in the LF group and 7.86 6 2.41 cm in the LF group at
24 wk of the intervention (P = 0.031).
Lipid profiles
Reductions in total cholesterol, LDL cholesterol, and tri-
glyceride concentrations and an increase in HDL cholesterol
were seen over the 24 wk of study in each group (P , 0.001).
However, there were no significant differences in these results
between the groups over 24 wk (Table2).
Glucose metabolism measurement
Data analysis showed that FPG, 2hpp glucose, glycated he-
moglobin, fasting serum insulin, and HOMA-IR all declined over
the 24 wk of study in each group (P, 0.001). However, between-
group comparisons were not significant for any variable (Table 2).
Food intake measurement
At baseline, there was no significant difference in energy and
macronutrient intake (Table 3). Estimated energy intake mea-
surements showed a significant reduction over time in both
groups (P , 0.001 for time effect). There were no significant
differences in energy and macronutrient intake between the 2
groups at the end of the 24-wk intervention, as shown in Table 3.
PA measurements
At baseline, both groups had similar mean daily steps of
w37576 315 in the HF group and 36086 550 in the LF group,
FIGURE 1 Screening, enrollment, random assignment, and follow-up of study participants. FD, food diary.
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as shown in Figure 2. Compared with baseline, both groups had
higher mean daily steps over time (P, 0.001 for time effect). In
addition, there was a significant group 3 time interaction for
mean daily steps over 24 wk between the 2 groups (P , 0.001,
2-factor ANOVA).
DISCUSSION
The main finding of the present study was that LF resulted in
significantly higher weight loss than did HF, with the same total
of 300min/wk for period of activity (11.7% compared with 9.5%)
in overweight and obese women while they were on a multidis-
ciplinary weight loss program.
The current guideline from the American College of Sports
Medicine that recommends moderate intensity PA of.250 min/wk
has been associated with clinically significant weight loss (28).
A recent clinical trial (29) also showed a beneficial effect of
moderate to vigorous exercise for 300 min/wk compared with
150 min/wk for reducing adiposity measures and body weight.
However, so far, the effects of different weekly patterns of PA on
weight loss are unknown.
A recent cross-sectional study (15) found that the frequency of
moderate to vigorous PA during the week is not as important as
the total volume of moderate to vigorous PA. However, this study
examined the association between the frequency of PA throughout
the week and metabolic syndrome in physically active adults, not
sedentary people who were following a weight loss program (15).
Unlike this previous observational study, to our knowledge, there
has not been a randomized controlled trial examining the conse-
quence for weight loss of either a weekly high- or low-frequency
PA pattern in overweight and obese premenopausal women who
were undertaking a voluntary integrated weight reduction pro-
gram for 24 wk.
The current study included a dietary intervention that has been
proven previously to achieve weight loss. Study participants lost
an amount of weight that was consistent with the dietary pre-
scription. In such intensive clinic-based behavioral lifestyle
modification programs, 5–10% weight losses have been detected
at 6 mo (30–32), which is similar to the weight losses that we
detected in the present study. This is not unexpected, because our
weight loss program includes energy restriction, frequent patient
visits to the clinic, and controlled and regular PA according the
protocol for each group. The results of the present study are also
in agreement with a study by Jakicic et al. (33) that demonstrated
that a combination of dietary modification and PA can improve
long-term weight loss.
Interestingly, participants in the LF group in our study lost
1.9 kg more weight than those in the HF group. It should be noted
TABLE 1
Baseline characteristics of the study groups1
LF group (n = 38) HF group (n = 37)
Age, y 29.4 6 5.7 29.7 6 5.8
Married 62 58
Anthropometric measures
Body weight, kg 82.6 6 7.3 81.4 6 7.5
Height, cm 160.5 6 3.9 159.7 6 4.0
BMI, kg/m2 32.1 6 2.6 31.9 6 2.6
WC, cm 98.3 6 8.9 98.2 6 9.0
Biochemical measures
TC, mmol/L 4.42 6 0.51 4.48 6 0.51
HDL cholesterol, mmol/L 1.16 6 0.20 1.18 6 0.14
LDL cholesterol, mmol/L 2.57 6 0.51 2.59 6 0.49
TGs, mmol/L 1.52 6 0.33 1.54 6 0.23
FPG, mmol/L 5.18 6 0.48 5.14 6 0.45
2hpp glucose, mmol/L 6.38 6 0.62 6.40 6 0.44
HbA1c, % 5.29 6 0.40 5.06 6 0.53
Insulin, mU/L 13.36 6 3.05 13.22 6 2.61
HOMA-IR 3.11 6 0.88 3.04 6 0.73
1Values are means 6 SDs or percentages, n = 75. Group difference
(with the use of an unpaired t test), P . 0.05. There were no significant
differences between groups at baseline. FPG, fasting plasma glucose;
HbA1c, glycated hemoglobin; HF, high-frequency physical activity; LF,
low-frequency physical activity; TC, total cholesterol; TG, triglyceride;
WC, waist circumference; 2hpp, 2-h postprandial.
TABLE 2
Anthropometric and blood measurement characteristics in the HF and LF groups before and after the 24-wk interventions1
LF group (n = 38) HF group (n = 37)
P2Baseline Week 24 Baseline Week 24
Weight,3 kg 82.62 6 7.30 73.05 6 6.49 81.35 6 7.49 73.57 6 7.14 0.028
BMI,3 kg/m2 32.09 6 2.57 28.94 6 2.47 31.90 6 2.61 28.47 6 2.18 0.029
WC,3 cm 98.32 6 8.85 88.96 6 7.58 98.24 6 8.99 90.38 6 8.37 0.031
TC,3 mmol/L 4.42 6 0.51 3.97 6 0.49 4.48 6 0.51 4.05 6 0.49 0.662
HDL cholesterol,3 mmol/L 1.16 6 0.20 1.30 6 0.21 1.18 6 0.14 1.32 6 0.14 0.754
LDL cholesterol,3 mmol/L 2.57 6 0.49 2.12 6 0.48 2.59 6 0.51 2.12 6 0.48 0.858
TGs,3 mmol/L 1.52 6 0.33 1.30 6 0.18 1.54 6 0.22 1.33 6 0.23 0.55
FPG,3 mmol/L 5.18 6 0.48 4.79 6 0.52 5.14 6 0.45 4.80 6 0.42 0.672
2hpp glucose,3 mmol/L 6.38 6 0.62 5.71 6 0.53 6.40 6 0.44 5.71 6 0.43 0.841
HbA1c,3 % 5.29 6 0.40 4.86 6 0.43 5.06 6 0.53 4.68 6 0.52 0.424
Insulin,3 mU/L 13.36 6 3.05 11.46 6 2.91 13.22 6 2.61 11.50 6 2.70 0.422
HOMA3 3.11 6 0.88 2.42 6 0.77 3.04 6 0.73 2.41 6 0.66 0.476
1Values are means 6 SDs, n = 75. FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HF, high-frequency
physical activity; LF, low-frequency physical activity; TC, total cholesterol; TG, triglyceride; WC, waist circumference;
2hpp, 2-h postprandial.
2 For LF relative to HF group with the use of ANCOVA with baseline values as a covariate.
3 Significant main effect of time, with the use of repeated-measures ANOVA, P , 0.001.
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that no significant differences in estimated energy intake were
seen between the 2 groups. Thus, the significant difference in
weight loss after 24 wk may be a result of differences in PA
between the groups outside the study protocol. Participants in the
LF groupmay have undertaken physical activity on the other days
of the week, which we did not request, perhaps because they had
developed a new PA habit. It is possible that there was better
compliance with the protocol in the LF group. In addition,
during prolonged, moderate-intensity, constant-rate exercise,
a cardiovascular drift can occur that may explain the weight loss
difference between the 2 groups of the intervention. The results of
the present study are consistent with a previous control study
which indicated that subjects lost more weight when they played
golf 2–3 times/wk compared with sedentary control group (34).
However, when elucidating the underlying mechanisms, finding
an explanation for the greater weight loss in the LF group than in
the HF group needs further long-term studies with accurate
accelerometer data or the use of doubly labeled water.
In the present study, major changes in lipid profiles and car-
bohydrate metabolism characteristics were significant in each
group, as we would expect, given the weight loss observed, but
these changes were similar in both groups. These results are
similar to the results of recent observational studies that indicate
the beneficial effects of accumulated moderate to vigorous PA
of $150 min/wk on cardiometabolic disease risk factors and
metabolic syndrome regardless of the frequency of PA throughout
the week (35).
These findings have clinical implications for the prescription
of PA that are consistent with the current guideline of.250 min/wk
PA for weight loss when sedentary overweight and obese adults
engage in an integrated weight loss program that includes an
energy-restricted diet and PA. Our results suggest that spending
the recommended length of time being active across a lower
frequency of PA sessions during a week could be associated with
more weight loss than being active most days of the week, as
recommended in the previous guidelines (6). Thus, people with
obesity who wish to lose weight but who either cannot or choose
not to undertake PA on most days may in fact experience benefit
if they undertake PA on 3 d for longer periods of time. It may
also indicate that the LF group was better able to comply with
PA protocol than the HF group, or that the LF group may have
undertaken more nonprescribed PA during the rest of the week.
Future research is required to examine the longer-term health
effects of LF compared with HF to establish whether the benefits
of LF are sustained.
There are limitations to this study that should be considered
when interpreting the results. First, this study was designed to test
whether LF would result in greater weight loss than would HF
throughout the week. However, accurate objective measurements
of PA characteristics, e.g., intensity and length of PA in the in-
tervention groups, were not made during the structured PA sessions
or over the rest of the day. These should be included in future
studies. Furthermore, because the majority of PA achieved in this
study was brisk walking, the effect of other forms of activity on
weight loss could not be determined. In addition, without long-
term follow-up, it is not known whether participants could comply
with the longer bouts of PA in the longer term.
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TABLE 3
Self-reported dietary intake in LF and HF groups before and after the 24-wk interventions1
Intake
LF group (n = 38) HF group (n = 37)
P2Baseline Week 24 Baseline Week 24
Total energy,3 kcal 2476 6 286 1947 6 181 2408 6 296 1913 6 290 0.805
Protein,3 g 91.1 6 8.8 79.4 6 9.4 87.2 6 8 74.3 6 10.1 0.141
Protein,3 % 14.9 6 2.1 16.4 6 2 14.7 6 2.1 15.6 6 1.8
Fat,3 g 97.6 6 17 69.7 6 9.4 92.8 6 20.3 65.6 6 13.2 0.287
Fat,3 % 35.3 6 2.9 32.1 6 2.3 34.4 6 4.3 30.7 6 2.3
Carbohydrate,3 g 308.3 6 35.3 250.7 6 26.5 306.2 6 35.4 256.3 6 38 0.201
Carbohydrate,3 % 49.8 6 1.6 51.5 6 2.4 51 6 2.9 53.6 6 1.8
Fiber,3 g 20.5 6 5.5 21.9 6 5.5 20.75 6 3.2 22.14 6 3.24 0.394
1Values are means 6 SDs, n = 75. HF, high-frequency physical activity; LF, low-frequency physical activity.
2 For LF relative to HF group with the use of ANCOVA with baseline values as a covariate.
3 Significant main effect of time, with the use of repeated-measures ANOVA, P , 0.001.
FIGURE 2 Mean 6 SEM step calculations with the use of a 3D pe-
dometer over the 24 wk of the intervention. At baseline, there were no
differences in step counts between the HF plus diet (n = 37) and LF plus
diet (n = 38) groups. There was a significant group 3 time interaction for
mean daily steps over 24 wk (P , 0.001; 2-factor ANOVA). HF, high-
frequency physical activity; LF, low-frequency physical activity.
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